1. Home
  2. MXE vs PPBT Comparison

MXE vs PPBT Comparison

Compare MXE & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mexico Equity and Income Fund Inc. (The)

MXE

Mexico Equity and Income Fund Inc. (The)

N/A

Current Price

$13.11

Market Cap

54.4M

Sector

Finance

ML Signal

N/A

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

N/A

Current Price

$4.22

Market Cap

45.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MXE
PPBT
Founded
1990
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.4M
45.3M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
MXE
PPBT
Price
$13.11
$4.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.3K
80.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.66%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.26
$0.41
52 Week High
$14.30
$5.18

Technical Indicators

Market Signals
Indicator
MXE
PPBT
Relative Strength Index (RSI) 44.36 77.72
Support Level $13.07 $0.57
Resistance Level $14.30 N/A
Average True Range (ATR) 0.30 0.27
MACD -0.17 0.37
Stochastic Oscillator 45.41 79.88

Price Performance

Historical Comparison
MXE
PPBT

About MXE Mexico Equity and Income Fund Inc. (The)

Mexico Equity and Income Fund Inc. is a closed-end, non-diversified management investment company that aims for long-term capital appreciation and current income. It prominently invests in equity, convertible securities, and debt issued by Mexican companies, operating across various sectors. The fund benchmarks its performance against the Mexbol and MSCI Mexico Index. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

Share on Social Networks: